Skip to main content
Equibles

MORGAN STANLEY

Position in NCNA — NuCana plc

CIK 895421 NEW YORK, NY
Back to NCNA Full portfolio

Position in NCNA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3
+$1 QoQ
Shares Held
2
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 10 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NCNA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,661,229 across 524 Biotechnology names. NCNA ranks #511 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in NCNA

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3 2
2026-03-31 $2 2
2025-12-31 $377 105
2025-09-30 $9 2
2024-12-31 $14,652 12,313
2024-09-30 $11,601 5,044
2024-06-30 $3,988 1,564
2024-03-31 $1,404 5,400
2022-12-31 $9,401 14,246
2022-09-30 $39,757 38,046
2022-06-30 $191 265
2022-03-31 $304 307
2021-12-31 $13,183 5,540
2021-09-30 $34,035 13,192
2021-06-30 $1,234,890 445,809
2021-03-31 $2,245 450
2020-09-30 $2,796 541
2020-06-30 $81 15
2020-03-31 $87 15